wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35752978-3B2F0AF6-7EA5-4483-9B82-CC27CA73A5F7
Q35752978-3B2F0AF6-7EA5-4483-9B82-CC27CA73A5F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35752978-3B2F0AF6-7EA5-4483-9B82-CC27CA73A5F7
Cross-market cost-effectiveness analysis of erlotinib as first-line maintenance treatment for patients with stable non-small cell lung cancer
P2860
Q35752978-3B2F0AF6-7EA5-4483-9B82-CC27CA73A5F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35752978-3B2F0AF6-7EA5-4483-9B82-CC27CA73A5F7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4210e1ffd356b92a101cbbf59e17d419545ac241
P2860
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.